CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway
Abstract Head and neck squamous cell carcinoma (HNSC) is the most common malignant tumor of head and neck. Due to the insidious nature of HNSC and the lack of effective early diagnostic indicators, the development of novel biomarkers to improve patient prognosis is particularly urgent. In this study...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-37950-z |
_version_ | 1797784649562324992 |
---|---|
author | Wenming Jia Shuai Chen Ran Wei Xiaoqi Yang Minfa Zhang Ye Qian Heng Liu Dapeng Lei |
author_facet | Wenming Jia Shuai Chen Ran Wei Xiaoqi Yang Minfa Zhang Ye Qian Heng Liu Dapeng Lei |
author_sort | Wenming Jia |
collection | DOAJ |
description | Abstract Head and neck squamous cell carcinoma (HNSC) is the most common malignant tumor of head and neck. Due to the insidious nature of HNSC and the lack of effective early diagnostic indicators, the development of novel biomarkers to improve patient prognosis is particularly urgent. In this study, we explored and validated the correlation between cytochrome P450 family 4 subfamily F member 12 (CYP4F12) expression levels and HNSC progression using data from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) datasets and collected patient samples. We analyzed the association of CYP4F12 expression with clinicopathological features, immune correlation and prognosis. Finally, we analyzed the correlation between CYP4F12 and pathways, and verified by experiments. The results showed that CYP4F12 was low expressed in tumor tissues, participated in a variety of phenotypic changes of HNSC and affected immune cell infiltration. Pathway analysis indicated that CYP4F12 may play a key role in tumor cell migration and apoptosis. Experimental results showed that over-expression of CYP4F12 inhibited cell migration and enhanced the adhesion between cells and matrix by inhibiting epithelial-mesenchymal transition (EMT) pathway in HNSC cells. In conclusion, our study provided insights into the role of CYP4F12 in HNSC and revealed that CYP4F12 may be a potential therapeutic target for HNSC. |
first_indexed | 2024-03-13T00:42:54Z |
format | Article |
id | doaj.art-c2f6a7e190f04009bc42ad2928db0da0 |
institution | Directory Open Access Journal |
issn | 2045-2322 |
language | English |
last_indexed | 2024-03-13T00:42:54Z |
publishDate | 2023-07-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj.art-c2f6a7e190f04009bc42ad2928db0da02023-07-09T11:13:15ZengNature PortfolioScientific Reports2045-23222023-07-0113111610.1038/s41598-023-37950-zCYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathwayWenming Jia0Shuai Chen1Ran Wei2Xiaoqi Yang3Minfa Zhang4Ye Qian5Heng Liu6Dapeng Lei7Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otolaryngology/Head and Neck Surgery, Institute of Otolaryngology, Affiliated Hospital of Binzhou Medical UniversityDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission (NHC) Key Laboratory of Otorhinolaryngology (Shandong University)Abstract Head and neck squamous cell carcinoma (HNSC) is the most common malignant tumor of head and neck. Due to the insidious nature of HNSC and the lack of effective early diagnostic indicators, the development of novel biomarkers to improve patient prognosis is particularly urgent. In this study, we explored and validated the correlation between cytochrome P450 family 4 subfamily F member 12 (CYP4F12) expression levels and HNSC progression using data from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) datasets and collected patient samples. We analyzed the association of CYP4F12 expression with clinicopathological features, immune correlation and prognosis. Finally, we analyzed the correlation between CYP4F12 and pathways, and verified by experiments. The results showed that CYP4F12 was low expressed in tumor tissues, participated in a variety of phenotypic changes of HNSC and affected immune cell infiltration. Pathway analysis indicated that CYP4F12 may play a key role in tumor cell migration and apoptosis. Experimental results showed that over-expression of CYP4F12 inhibited cell migration and enhanced the adhesion between cells and matrix by inhibiting epithelial-mesenchymal transition (EMT) pathway in HNSC cells. In conclusion, our study provided insights into the role of CYP4F12 in HNSC and revealed that CYP4F12 may be a potential therapeutic target for HNSC.https://doi.org/10.1038/s41598-023-37950-z |
spellingShingle | Wenming Jia Shuai Chen Ran Wei Xiaoqi Yang Minfa Zhang Ye Qian Heng Liu Dapeng Lei CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway Scientific Reports |
title | CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway |
title_full | CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway |
title_fullStr | CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway |
title_full_unstemmed | CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway |
title_short | CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway |
title_sort | cyp4f12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via emt pathway |
url | https://doi.org/10.1038/s41598-023-37950-z |
work_keys_str_mv | AT wenmingjia cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway AT shuaichen cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway AT ranwei cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway AT xiaoqiyang cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway AT minfazhang cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway AT yeqian cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway AT hengliu cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway AT dapenglei cyp4f12isapotentialbiomarkerandinhibitscellmigrationofheadandnecksquamouscellcarcinomaviaemtpathway |